The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 17, 2014

Filed:

May. 13, 2011
Applicants:

Thomas Daniel Aicher, Ann Arbor, MI (US);

Josef Roland Bencsik, LaSalle, CA;

Kevin Ronald Condroski, San Diego, CA (US);

Jay Bradford Fell, Boulder, CO (US);

John P. Fischer, Boulder, CO (US);

Ronald Jay Hinklin, Boulder, CO (US);

Scott Alan Pratt, Longmont, CO (US);

Ajay Singh, Broomfield, CO (US);

Timothy M. Turner, Longmont, CO (US);

David A. Mareska, McMurray, PA (US);

Steven Armen Boyd, Pittsburgh, PA (US);

Inventors:

Thomas Daniel Aicher, Ann Arbor, MI (US);

Josef Roland Bencsik, LaSalle, CA;

Kevin Ronald Condroski, San Diego, CA (US);

Jay Bradford Fell, Boulder, CO (US);

John P. Fischer, Boulder, CO (US);

Ronald Jay Hinklin, Boulder, CO (US);

Scott Alan Pratt, Longmont, CO (US);

Ajay Singh, Broomfield, CO (US);

Timothy M. Turner, Longmont, CO (US);

David A. Mareska, McMurray, PA (US);

Steven Armen Boyd, Pittsburgh, PA (US);

Assignee:

Array BioPharma Inc., Boulder, CO (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 43/40 (2006.01); A61K 31/445 (2006.01); A61K 31/44 (2006.01); C07D 401/00 (2006.01); C07D 405/00 (2006.01); C07D 409/00 (2006.01); C07D 411/00 (2006.01); C07D 413/00 (2006.01); C07D 417/00 (2006.01); C07D 419/00 (2006.01); C07D 421/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which X, X, L, R, R, R, R, R, R, R, R, and n have the meanings given in the specification, are modulators of GPR119 and are useful in the treatment or prevention of diseases such as such as, but not limited to, type 2 diabetes, diabetic complications, symptoms of diabetes, metabolic syndrome, obesity, dyslipidemia, and related conditions.


Find Patent Forward Citations

Loading…